$47.36
al cierre: Oct 27 EDT
$47.36
0.000.00%
Pre-comercialización: 4:00 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Conmed informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 5
Estimación de BPA
$1.050
Estimación de ingresos trimestrales
$335.46M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$1.33B
Analice el historial de beneficios de Conmed utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CNMD | Conmed | $1.05 | $1.05 | — | — | $316.70M | $335.46M | — | — | 11/05/2025 | |
CNMD | Conmed | $0.98 | $1.13 | $1.15 | 1.77% | $332.10M | $338.89M | $342.35M | 1.02% | 07/30/2025 | |
CNMD | Conmed | $0.79 | $0.81 | $0.95 | 17.28% | $312.27M | $313.38M | $321.30M | 2.53% | 04/30/2025 | |
CNMD | Conmed | $1.06 | $1.20 | $1.34 | 11.67% | $327.05M | $341.05M | $345.94M | 1.43% | 02/05/2025 | |
CNMD | Conmed | $0.90 | $0.99 | $1.05 | 6.06% | $304.58M | $318.13M | $316.70M | -0.45% | 10/30/2024 | |
CNMD | Conmed | $0.83 | $0.91 | $0.98 | 7.69% | $317.65M | $332.32M | $332.10M | -0.07% | 07/31/2024 | |
CNMD | Conmed | $0.66 | $0.74 | $0.79 | 6.76% | $295.47M | $306.78M | $312.27M | 1.79% | 04/24/2024 | |
CNMD | Conmed | $0.42 | $1.11 | $1.06 | -4.50% | $250.87M | $332.20M | $327.05M | -1.55% | 01/31/2024 | |
CNMD | Conmed | $0.77 | $0.83 | $0.90 | 8.43% | $275.09M | $300.91M | $304.58M | 1.22% | 10/25/2023 | |
CNMD | Conmed | $0.76 | $0.79 | $0.83 | 5.06% | $277.19M | $306.09M | $317.65M | 3.78% | 07/26/2023 | |
CNMD | Conmed | $0.70 | $0.60 | $0.66 | 10.00% | $242.33M | $266.67M | $295.47M | 10.80% | 04/26/2023 | |
CNMD | Conmed | $1.07 | $0.90 | $0.42 | -53.33% | $273.97M | $302.51M | $250.87M | -17.07% | 02/02/2023 | |
CNMD | Conmed | $0.80 | $0.75 | $0.77 | 2.67% | $248.83M | $280.56M | $275.09M | -1.95% | 10/26/2022 | |
CNMD | Conmed | $0.71 | $0.75 | $0.76 | 1.33% | $255.16M | $274.20M | $277.19M | 1.09% | 07/27/2022 | |
CNMD | Conmed | $0.63 | $0.62 | $0.70 | 12.90% | $232.68M | $235.77M | $242.33M | 2.78% | 05/04/2022 | |
CNMD | Conmed | $0.84 | $1.06 | $1.07 | 0.94% | $252.83M | $278.76M | $273.97M | -1.72% | 01/26/2022 | |
CNMD | Conmed | $0.88 | $0.76 | $0.80 | 5.26% | $237.84M | $255.53M | $248.83M | -2.62% | 10/27/2021 | |
CNMD | Conmed | -$0.07 | $0.62 | $0.71 | 14.52% | $157.78M | $248.31M | $255.16M | 2.76% | 07/28/2021 | |
CNMD | Conmed | $0.51 | $0.44 | $0.63 | 43.18% | $214.01M | $216.88M | $232.68M | 7.28% | 04/28/2021 | |
CNMD | Conmed | $0.90 | $0.76 | $0.84 | 10.53% | $264.87M | $262.94M | $252.83M | -3.85% | 01/27/2021 | |
CNMD | Conmed | $0.62 | $0.23 | $0.88 | 282.61% | $233.59M | $205.92M | $237.84M | 15.50% | 10/28/2020 |
Conmed (CNMD) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-30 | $1.15 | $1.13 | 1.77 % |
| Q1 | 2025-04-30 | $0.95 | $0.81 | 17.3 % |
| Q4 | 2025-02-05 | $1.34 | $1.20 | 11.7 % |
| Q3 | 2024-10-30 | $1.05 | $0.99 | 6.06 % |
Conmed (CNMD) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-30 | $342.35M | $338.89M | 1.02 % |
| Q1 | 2025-04-30 | $321.30M | $313.38M | 2.53 % |
| Q4 | 2025-02-05 | $345.94M | $341.05M | 1.43 % |
| Q3 | 2024-10-30 | $316.70M | $318.13M | -0.45 % |
PREGUNTAS FRECUENTES
¿Cuándo Conmed (NYSE:CNMD) publicará los resultados?
Está previsto que Conmed (CNMD) presente resultados el noviembre 5, 2025. Los últimos resultados se publicaron el julio 30, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Conmed (NYSE:CNMD)?
El BPA real fue de $1.15, que superó la estimación de $1.13.
¿Cuáles fueron los ingresos de Conmed (NYSE:CNMD)?
Los ingresos reales fueron $342.3M, que superó la estimación de $338.9M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.